Capital Analysts LLC boosted its holdings in Zoetis Inc. (NYSE:ZTS – Free Report) by 4.1% in the 1st quarter, according to its most recent filing with the Securities & Exchange Commission. The institutional investor owned 45,263 shares of the company’s stock after purchasing an additional 1,770 shares during the quarter. Capital Analysts LLC’s holdings in Zoetis were worth $7,533,000 at the end of the most recent reporting period.
Other institutional investors and hedge funds have also recently added to or reduced their stakes in the company. Empirical Financial Services LLC d.b.a. Empirical Wealth Management increased its stake in Zoetis by 3.4% in the 4th quarter. Empirical Financial Services LLC d.b.a. Empirical Wealth Management now owns 1,866 shares of the company’s stock valued at $273,000 after buying an additional 62 shares during the last quarter. M Holdings Securities Inc. grew its position in shares of Zoetis by 2.2% in the 4th quarter. M Holdings Securities Inc. now owns 2,931 shares of the company’s stock worth $430,000 after buying an additional 64 shares during the period. Lake Street Financial LLC grew its holdings in shares of Zoetis by 2.4% during the first quarter. Lake Street Financial LLC now owns 2,733 shares of the company’s stock valued at $455,000 after buying an additional 64 shares during the last quarter. Newbridge Financial Services Group Inc. grew its position in shares of Zoetis by 21.2% during the 1st quarter. Newbridge Financial Services Group Inc. now owns 366 shares of the company’s stock valued at $61,000 after acquiring an additional 64 shares during the period. Finally, Salem Investment Counselors Inc. raised its position in shares of Zoetis by 8.8% during the 4th quarter. Salem Investment Counselors Inc. now owns 800 shares of the company’s stock valued at $117,000 after purchasing an additional 65 shares during the period. 98.18% of the stock is currently owned by institutional investors.
Analyst Ratings Changes
Several equities research analysts have recently weighed in on ZTS shares. StockNews.com initiated coverage on Zoetis in a report on Thursday, May 18th. They issued a “buy” rating on the stock. Bank Of America (Bofa) boosted their target price on shares of Zoetis from $180.00 to $200.00 and gave the company a “buy” rating in a research report on Tuesday, April 11th. Finally, Piper Sandler reduced their target price on Zoetis from $220.00 to $210.00 in a research note on Monday, May 8th. Seven analysts have rated the stock with a buy rating, Based on data from MarketBeat, Zoetis presently has an average rating of “Buy” and a consensus target price of $220.50.
Zoetis Price Performance
Shares of NYSE:ZTS traded down $3.40 during midday trading on Wednesday, hitting $182.11. 2,284,752 shares of the stock were exchanged, compared to its average volume of 2,042,413. The company has a current ratio of 3.27, a quick ratio of 1.94 and a debt-to-equity ratio of 1.46. The company has a 50 day moving average price of $171.72 and a 200-day moving average price of $170.69. Zoetis Inc. has a twelve month low of $124.15 and a twelve month high of $194.99. The stock has a market cap of $84.15 billion, a P/E ratio of 41.88, a PEG ratio of 3.04 and a beta of 0.78.
Zoetis (NYSE:ZTS – Get Free Report) last posted its quarterly earnings data on Thursday, May 4th. The company reported $1.31 EPS for the quarter, beating analysts’ consensus estimates of $1.27 by $0.04. The company had revenue of $2 billion during the quarter, compared to the consensus estimate of $2.02 billion. Zoetis had a net margin of 25.59% and a return on equity of 50.26%. The company’s quarterly revenue was up .7% compared to the same quarter last year. During the same quarter in the prior year, the company posted $1.32 EPS. On average, research analysts forecast that Zoetis Inc. will post 5.41 earnings per share for the current year.
Zoetis Announces Dividend
The company also recently announced a quarterly dividend, which will be paid on Friday, September 1st. Investors of record on Friday, July 21st will be issued a dividend of $0.375 per share. This represents a $1.50 dividend on an annualized basis and a yield of 0.82%. The ex-dividend date of this dividend is Thursday, July 20th. Zoetis’s payout ratio is currently 33.86%.
Zoetis Company Profile
Zoetis Inc discovers, develops, manufactures, and commercializes animal health medicines, vaccines, and diagnostic products in the United States and internationally. It commercializes products primarily across species, including livestock, such as cattle, swine, poultry, fish, and sheep and others; and companion animals comprising dogs, cats, and horses.